Beta73% was sold under disclosed trading plans, 27% with no plan disclosed. The largest seller, George LeMaitre (Chairman and CEO, Director), sold $27.1M.Share-of-stake figures for this company are being verified and will be added when that check is finished. Why
A share of stake is shown for 0 of the 5 officers and directors who sold. 10 are left out Disclosed company stock is not an insider's whole wealth.i
Left out: George LeMaitre, John O'Connor, David Roberts, Joseph Pellegrino Jr., Lawrence Jasinski, Trent Kamke, John Roush, Bridget Ross, Martha Shadan and Dorian LeBlanc (share of stake is being verified).
Officers and directors, past 12 months. Their share of stake is being verified and is not shown yet; amounts and trading plans are below.
Officers and directors, Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
No officer or director trades were reported for the past 30 days. The most recent before that:
| Who | Shares | Price | % of total stake | Total stake after | Trade date | Filed |
|---|---|---|---|---|---|---|
| George LeMaitre Chairman and CEO, Director | 11,974 | n/a | n/a | n/a | Jun 4, 2026 | Jun 5, 2026 |
Yes. George LeMaitre sold 252K shares ($27.1M) in the past 12 months, 81% of it under a trading plan disclosed in the filings.
Filings rarely give a reason, and we don't guess at one. What they show is how the sales were made: 73% of sales by value ran under 10b5-1 trading plans disclosed in the filings and 27% had no disclosed plan. A trading plan schedules sales in advance.
No. Officers and directors reported no purchases in the past 12 months.
| Who sold | Amount | % of holdings | Trading plan |
|---|---|---|---|
| George LeMaitre Chairman and CEO, Director | $27.1M 252K shares | Not confirmedshare of stake is being verified. Why | 81% under a disclosed plan 19% no plan disclosed |
| David Roberts President and Director, Director | $1.3M 12K shares | Not confirmedshare of stake is being verified. Why | No plan disclosed |
| Trent Kamke Senior V. P., Operations | $713K 6.6K shares | Not confirmedshare of stake is being verified. Why | No plan disclosed |
| Bridget Ross Director | $560K 5K shares | Not confirmedshare of stake is being verified. Why | No plan disclosed |
| Lawrence Jasinski Director | $434K 3.9K shares | Not confirmedshare of stake is being verified. Why | No plan disclosed |
Vested shares across all share classes, held directly and through trusts, LLCs and family members, as reported on SEC Forms 3, 4 and 5. Unvested awards and options are never counted as owned shares.
| Insider | Held Oct 16, 2025 | Sold | Held Oct 16, 2026 | Still held | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
George LeMaitre!Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for George LeMaitre are complete. Chairman and CEO, Director | n/a | −252K | n/a | n/a | ||||||||||||||||||||||||||||||||||||
Vesting, gifts, unvested awards and holding lines for George LeMaitreHoldings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for George LeMaitre are complete; balances and unit counts will be added when the check is finished. −29Kgifted (net of own trusts) −4.7Kwithheld by the company for taxes Stock options (not counted as shares):
Estimate: options held × ($108.69 − strike price), using the most recent insider trade price on Form 4 (May 8, 2026), not a market close. | ||||||||||||||||||||||||||||||||||||||||
John O'Connor!Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for John O'Connor are complete. Director | n/a | 0 | n/a | n/a | ||||||||||||||||||||||||||||||||||||
Vesting, gifts, unvested awards and holding lines for John O'ConnorHoldings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for John O'Connor are complete; balances and unit counts will be added when the check is finished. −3Kgifted (net of own trusts) Stock options (not counted as shares):
Estimate: options held × ($108.69 − strike price), using the most recent insider trade price on Form 4 (May 8, 2026), not a market close. | ||||||||||||||||||||||||||||||||||||||||
David Roberts!Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. See the filing Sales and other transactions for David Roberts are complete. President and Director, Director | n/a | −12K | n/a | n/a | ||||||||||||||||||||||||||||||||||||
Vesting, gifts, unvested awards and holding lines for David RobertsHoldings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for David Roberts are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) −1.7Kwithheld by the company for taxes Stock options (not counted as shares):
Estimate: options held × ($108.69 − strike price), using the most recent insider trade price on Form 4 (May 8, 2026), not a market close. | ||||||||||||||||||||||||||||||||||||||||
Joseph Pellegrino Jr.!Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Joseph Pellegrino Jr. are complete. Director | n/a | 0 | n/a | n/a | ||||||||||||||||||||||||||||||||||||
Vesting, gifts, unvested awards and holding lines for Joseph Pellegrino Jr.Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Joseph Pellegrino Jr. are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) Stock options (not counted as shares):
Estimate: options held × ($108.69 − strike price), using the most recent insider trade price on Form 4 (May 8, 2026), not a market close. | ||||||||||||||||||||||||||||||||||||||||
Lawrence Jasinski!Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Lawrence Jasinski are complete. Director | n/a | −3.9K | n/a | n/a | ||||||||||||||||||||||||||||||||||||
Vesting, gifts, unvested awards and holding lines for Lawrence JasinskiHoldings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Lawrence Jasinski are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) Stock options (not counted as shares):
Estimate: options held × ($108.69 − strike price), using the most recent insider trade price on Form 4 (May 8, 2026), not a market close. | ||||||||||||||||||||||||||||||||||||||||
Trent Kamke!Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Trent Kamke are complete. Senior V. P., Operations | n/a | −6.6K | n/a | n/a | ||||||||||||||||||||||||||||||||||||
Vesting, gifts, unvested awards and holding lines for Trent KamkeHoldings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Trent Kamke are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) −654withheld by the company for taxes Stock options (not counted as shares):
Estimate: options held × ($108.69 − strike price), using the most recent insider trade price on Form 4 (May 8, 2026), not a market close. | ||||||||||||||||||||||||||||||||||||||||
John Roush!Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. See the filing Sales and other transactions for John Roush are complete. Director | n/a | 0 | n/a | n/a | ||||||||||||||||||||||||||||||||||||
Vesting, gifts, unvested awards and holding lines for John RoushHoldings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for John Roush are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) Stock options (not counted as shares):
Estimate: options held × ($108.69 − strike price), using the most recent insider trade price on Form 4 (May 8, 2026), not a market close. | ||||||||||||||||||||||||||||||||||||||||
Bridget Ross!Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Bridget Ross are complete. Director | n/a | −5K | n/a | n/a | ||||||||||||||||||||||||||||||||||||
Vesting, gifts, unvested awards and holding lines for Bridget RossHoldings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Bridget Ross are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) Stock options (not counted as shares):
Estimate: options held × ($108.69 − strike price), using the most recent insider trade price on Form 4 (May 8, 2026), not a market close. | ||||||||||||||||||||||||||||||||||||||||
Martha Shadan!Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Martha Shadan are complete. Director | n/a | 0 | n/a | n/a | ||||||||||||||||||||||||||||||||||||
Vesting, gifts, unvested awards and holding lines for Martha ShadanHoldings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Martha Shadan are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) Stock options (not counted as shares):
Estimate: options held × ($108.69 − strike price), using the most recent insider trade price on Form 4 (May 8, 2026), not a market close. | ||||||||||||||||||||||||||||||||||||||||
Dorian LeBlanc!Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Dorian LeBlanc are complete. Chief Financial Officer | n/a | 0 | n/a | n/a | ||||||||||||||||||||||||||||||||||||
Vesting, gifts, unvested awards and holding lines for Dorian LeBlancHoldings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Dorian LeBlanc are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts) −96withheld by the company for taxes Stock options (not counted as shares):
Estimate: options held × ($108.69 − strike price), using the most recent insider trade price on Form 4 (May 8, 2026), not a market close. | ||||||||||||||||||||||||||||||||||||||||
Holdings and share of stake for Lemaitre Vascular Inc are being verified, so no balances, unit counts or percentages are shown. Sales, proceeds, plan and tax status, titles and dates come straight from individual filings.
Officer and director open-market sales: $30.0M across 279,771 shares. Plan status and stated purpose are separate questions, and a sale can have both.
The lighter segment is sales with no plan disclosed in the filing ($8.0M), including tax-related sales outside a plan.
Sales with no 10b5-1 plan and no tax reference in the filing. $5.0M of it is George LeMaitre. No plan disclosed is a statement about the filing, not about why the sale happened. Largest such sale: George LeMaitre, May 8, 2026
7,179 shares ($625K) were withheld by the company for taxes, which isn't a market sale.
| Seller | Shares sold | Proceeds | Under a disclosed plan | Share of total | Sales dates |
|---|---|---|---|---|---|
| George LeMaitre Chairman and CEO, Director | 252K | $27.1M | 81% | 90% | Feb 26, 2026 to May 8, 2026 |
| David Roberts President and Director, Director | 12K | $1.3M | 0% | 4% | Feb 27, 2026 to Mar 11, 2026 |
| Trent Kamke Senior V. P., Operations | 6.6K | $713K | 0% | 2% | Feb 27, 2026 to May 8, 2026 |
| Bridget Ross Director | 5K | $560K | 0% | 2% | May 7, 2026 to May 7, 2026 |
| Lawrence Jasinski Director | 3.9K | $434K | 0% | 1% | May 7, 2026 to May 7, 2026 |
| Month | Sale proceeds | Disclosed plan | To cover taxes | No plan disclosed |
|---|---|---|---|---|
| Oct 2025 | $0 | $0 | $0 | $0 |
| Nov 2025 | $0 | $0 | $0 | $0 |
| Dec 2025 | $0 | $0 | $0 | $0 |
| Jan 2026 | $0 | $0 | $0 | $0 |
| Feb 2026 | $17.0M | $16.0M | $0 | $1.0M |
| Mar 2026 | $6.7M | $6.0M | $0 | $641K |
| Apr 2026 | $0 | $0 | $0 | $0 |
| May 2026 | $6.3M | $0 | $0 | $6.3M |
| Jun 2026 | $0 | $0 | $0 | $0 |
| Jul 2026 | $0 | $0 | $0 | $0 |
| Aug 2026 | $0 | $0 | $0 | $0 |
| Sep 2026 | $0 | $0 | $0 | $0 |
| Oct 2026 | $0 | $0 | $0 | $0 |
In line with the past 5 years. 5 insiders sold; the average is 6 a year.
| 12 months ending | Shares sold | Insiders who sold | Proceeds |
|---|---|---|---|
| Oct 16, 2026 Latest 12 months | 280K | 5 | $30.0M |
| Oct 16, 2025 1 year earlier | 241K | 7 | $21.6M |
| Oct 16, 2024 2 years earlier | 540K | 7 | $39.4M |
| Oct 17, 2023 3 years earlier | 224K | 6 | $13.5M |
| Oct 17, 2022 4 years earlier | 148K | 4 | $8.0M |
| Oct 17, 2021 5 years earlier | 794K | 6 | $36.0M |
Open-market sales (Form 4 code S) by people who were officers or directors, in split-adjusted shares. Earlier years include people who have since left. A sale that an outside holder also reports (a family trust, a fund) is counted with outside holders in every year. Shares, not dollars, are compared, so a change in the stock price doesn't look like a change in selling. Years the filings don't fully cover are shown but left out of the average.
Holdings and share of stake are being verified. Balances, unit counts and every share-of-stake figure for Lemaitre Vascular Inc are held back until that check is finished. Sales, proceeds, plan and tax status, titles and dates come straight from individual filings and are complete.
External context: we only cite outside events when a documented connection exists. None is shown for this period.
All 1,380 Forms 3, 4 and 5 on record for Lemaitre Vascular Inc (SEC CIK 1158895), filed from Oct 18, 2006 to Sep 8, 2026; 92 of them were filed in the 12 months this page covers, retrieved from SEC EDGAR on Oct 16, 2026. Prices are the ones reported in each filing, often weighted averages.
Holdings. Each holding line (a share class plus an owner, such as a trust or LLC) carries its last reported balance forward. Entities first reported during the period start at zero, so transfers between an insider's own trusts don't count as selling. Lines not reported for three years or more are listed separately and left out of totals.
Sales. A sale counts as under a 10b5-1 plan if its footnote cites one or the filing's Rule 10b5-1 box is checked, and as tax-related if its footnote cites tax obligations or sell-to-cover. Shares withheld by the company for taxes are listed separately. Sales with neither attribute are labeled "no plan disclosed".
Spotted something wrong on this page? Report an error. We check every report against the SEC filing and list what we fix in the corrections log.